Skip to main content
Erschienen in: Documenta Ophthalmologica 1/2015

01.02.2015 | Clinical Case Report

Retinal toxicity after intracameral use of a standard dose of cefuroxime during cataract surgery

verfasst von: Céline Faure, Daniel Perreira, Isabelle Audo

Erschienen in: Documenta Ophthalmologica | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We report the clinical findings and retinal function of a patient who presented retinal toxicity signs after cefuroxime use for a phacoemulsification surgery.

Methods

A 64-year-old man underwent a technically uneventful left eye cataract surgery. A standard intracameral dose of cefuroxime (0.1 mL of 10.0 mg/mL solution) was administered at the end of the surgery.

Results

At review 2 days later, he complained about left eye visual loss. Fundus examination revealed a diffuse retinal pallor with small intraretinal cysts. Optical coherence tomography scans showed a large retinal serous detachment with a schisis-like appearance of the outer nuclear layer. A slight global retinal dysfunction was recorded on ISCEV full-field electroretinogram. Fast clinical recovery was observed. Optical coherence tomography scans were back to normal within less than a week. Two months later, full-field electroretinogram showed no longer abnormalities.

Conclusion

It is the first report to our knowledge of a case of retinal toxicity with a standard dose. Kinetics and studies about cefuroxime toxicity are reviewed and discussed.
Literatur
1.
Zurück zum Zitat Montan PG, Weide G, Setterquist H, Rylander M, Zetterström C (2002) Prophylactic intracameral cefuroxime. Evaluation of safety and kinetics in cataract surgery. J Cataract Refract Surg 28(6):982–987PubMedCrossRef Montan PG, Weide G, Setterquist H, Rylander M, Zetterström C (2002) Prophylactic intracameral cefuroxime. Evaluation of safety and kinetics in cataract surgery. J Cataract Refract Surg 28(6):982–987PubMedCrossRef
2.
Zurück zum Zitat Barry P, Seal DV, Gettinby G, Lees F, Peterson M, Revie CW, for the ESCRS Endophthalmitis Study Group (2006) ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; preliminary results from a European multicenter study. J Cataract Refract Surg 32:407–410PubMedCrossRef Barry P, Seal DV, Gettinby G, Lees F, Peterson M, Revie CW, for the ESCRS Endophthalmitis Study Group (2006) ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; preliminary results from a European multicenter study. J Cataract Refract Surg 32:407–410PubMedCrossRef
3.
Zurück zum Zitat Lam PT, Young AL, Cheng LL, Tam PM, Lee VY (2010) Randomized controlled trial on the safety of intracameral cephalosporins in cataract surgery. Clin Ophthalmol 8(4):1499–1504 Lam PT, Young AL, Cheng LL, Tam PM, Lee VY (2010) Randomized controlled trial on the safety of intracameral cephalosporins in cataract surgery. Clin Ophthalmol 8(4):1499–1504
4.
Zurück zum Zitat Gupta MS, McKee HD, Saldana M, Stewart OG (2005) Macular thickness after cataract surgery with intracameral cefuroxime. J Cataract Refract Surg 31(6):1163–1166PubMedCrossRef Gupta MS, McKee HD, Saldana M, Stewart OG (2005) Macular thickness after cataract surgery with intracameral cefuroxime. J Cataract Refract Surg 31(6):1163–1166PubMedCrossRef
5.
Zurück zum Zitat Hann JV, Lee LR (2006) Macular thickness after cataract surgery with intracameral cefuroxime. J Cataract Refract Surg 32(4):545 (author reply 545)PubMedCrossRef Hann JV, Lee LR (2006) Macular thickness after cataract surgery with intracameral cefuroxime. J Cataract Refract Surg 32(4):545 (author reply 545)PubMedCrossRef
6.
Zurück zum Zitat Olavi P (2012) Ocular toxicity in cataract surgery because of inaccurate preparation and erroneous use of 50 mg/ml intracameral cefuroxime. Acta Ophthalmol 90(2):e153 Olavi P (2012) Ocular toxicity in cataract surgery because of inaccurate preparation and erroneous use of 50 mg/ml intracameral cefuroxime. Acta Ophthalmol 90(2):e153
7.
Zurück zum Zitat Delyfer MN, Rougier MB, Leoni S, Zhang Q, Dalbon F, Colin J, Korobelnik JF (2011) Ocular toxicity after intracameral injection of very high doses of cefuroxime during cataract surgery. J Cataract Refract Surg 37(2):271–278PubMedCrossRef Delyfer MN, Rougier MB, Leoni S, Zhang Q, Dalbon F, Colin J, Korobelnik JF (2011) Ocular toxicity after intracameral injection of very high doses of cefuroxime during cataract surgery. J Cataract Refract Surg 37(2):271–278PubMedCrossRef
8.
Zurück zum Zitat Qureshi F, Clark D (2011) Macular infarction after inadvertent intracameral cefuroxime. J Cataract Refract Surg 37(6):1168–1169PubMedCrossRef Qureshi F, Clark D (2011) Macular infarction after inadvertent intracameral cefuroxime. J Cataract Refract Surg 37(6):1168–1169PubMedCrossRef
9.
Zurück zum Zitat Sakarya Y, Sakarya R (2010) Cefuroxime dilution error. Eur J Ophthalmol 20(2):460–461PubMed Sakarya Y, Sakarya R (2010) Cefuroxime dilution error. Eur J Ophthalmol 20(2):460–461PubMed
10.
Zurück zum Zitat Yoeruek E, Spitzer MS, Saygili O, Tatar O, Biedermann T, Yoeruek E, Bartz-Schmidt KU, Szurman P (2008) Comparison of in vitro safety profiles of vancomycin and cefuroxime on human corneal endothelial cells for intracameral use. J Cataract Refract Surg 34(12):2139–2145PubMedCrossRef Yoeruek E, Spitzer MS, Saygili O, Tatar O, Biedermann T, Yoeruek E, Bartz-Schmidt KU, Szurman P (2008) Comparison of in vitro safety profiles of vancomycin and cefuroxime on human corneal endothelial cells for intracameral use. J Cataract Refract Surg 34(12):2139–2145PubMedCrossRef
11.
Zurück zum Zitat Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M (2009) International Society for Clinical Electrophysiology of Vision. ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol 118(1):69–77PubMedCrossRef Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M (2009) International Society for Clinical Electrophysiology of Vision. ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol 118(1):69–77PubMedCrossRef
12.
Zurück zum Zitat Lockington D, Flowers H, Young D, Yorston D (2010) Assessing the accuracy of intracameral antibiotic preparation for use in cataract surgery. J Cataract Refract Surg 36(2):286–289PubMedCrossRef Lockington D, Flowers H, Young D, Yorston D (2010) Assessing the accuracy of intracameral antibiotic preparation for use in cataract surgery. J Cataract Refract Surg 36(2):286–289PubMedCrossRef
13.
Zurück zum Zitat Hui M, Lam PT, Cheung SW, Pang CP, Chan CY, Lam DS (2011) In vitro compatibility study of cephalosporin with intraocular irrigating solutions and intracameral medications. Clin Exp Ophthalmol 39(2):164–170CrossRef Hui M, Lam PT, Cheung SW, Pang CP, Chan CY, Lam DS (2011) In vitro compatibility study of cephalosporin with intraocular irrigating solutions and intracameral medications. Clin Exp Ophthalmol 39(2):164–170CrossRef
14.
Zurück zum Zitat Shaarawy A, Meredith TA, Kincaid M, Dick J, Aguilar E, Ritchie DJ, Reichley RM (1995) Intraocular injection of ceftazidime. Effects of inflammation and surgery. Retina 15(5):433–438PubMedCrossRef Shaarawy A, Meredith TA, Kincaid M, Dick J, Aguilar E, Ritchie DJ, Reichley RM (1995) Intraocular injection of ceftazidime. Effects of inflammation and surgery. Retina 15(5):433–438PubMedCrossRef
15.
Zurück zum Zitat Kwok AK, Hui M, Pang CP, Chan RC, Cheung SW, Yip CM, Lam DS, Cheng AF (2002) An in vitro study of ceftazidime and vancomycin concentrations in various fluid media: implications for use in treating endophthalmitis. Invest Ophthalmol Vis Sci 43(4):1182–1188PubMed Kwok AK, Hui M, Pang CP, Chan RC, Cheung SW, Yip CM, Lam DS, Cheng AF (2002) An in vitro study of ceftazidime and vancomycin concentrations in various fluid media: implications for use in treating endophthalmitis. Invest Ophthalmol Vis Sci 43(4):1182–1188PubMed
16.
Zurück zum Zitat Aguilar HE, Meredith TA, El-Massry A, Shaarawy A, Kincaid M, Dick J, Ritchie DJ, Reichley RM, Neisman MK (1995) Vancomycin levels after intravitreal injection. Effects of inflammation and surgery. Retina 15(5):428–432PubMedCrossRef Aguilar HE, Meredith TA, El-Massry A, Shaarawy A, Kincaid M, Dick J, Ritchie DJ, Reichley RM, Neisman MK (1995) Vancomycin levels after intravitreal injection. Effects of inflammation and surgery. Retina 15(5):428–432PubMedCrossRef
17.
Zurück zum Zitat Koul S, Philipson A, Philipson BT, Arvidson S (1993) Intraocular levels of cefuroxime in inflamed rabbit eyes. Eur J Ophthalmol 3(2):61–65PubMed Koul S, Philipson A, Philipson BT, Arvidson S (1993) Intraocular levels of cefuroxime in inflamed rabbit eyes. Eur J Ophthalmol 3(2):61–65PubMed
18.
Zurück zum Zitat Shahar J, Zemel E, Perlman I, Loewenstein A (2012) Physiological and toxicological effects of cefuroxime on the albino rabbit retina. Invest Ophthalmol Vis Sci 53(2):906–914PubMedCrossRef Shahar J, Zemel E, Perlman I, Loewenstein A (2012) Physiological and toxicological effects of cefuroxime on the albino rabbit retina. Invest Ophthalmol Vis Sci 53(2):906–914PubMedCrossRef
19.
Zurück zum Zitat Jain N, Bhatti MT (2012) Fingolimod-associated macular edema : incidence, detection and management. Neurology 78(9):672–680PubMedCrossRef Jain N, Bhatti MT (2012) Fingolimod-associated macular edema : incidence, detection and management. Neurology 78(9):672–680PubMedCrossRef
20.
Zurück zum Zitat Zarbin MA, Jampol LM, Jager RD, Reder AT, Francis G, Collins W, Tang D, Zhang X (2013) Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis. Ophthalmology 120(7):1432–1439PubMedCrossRef Zarbin MA, Jampol LM, Jager RD, Reder AT, Francis G, Collins W, Tang D, Zhang X (2013) Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis. Ophthalmology 120(7):1432–1439PubMedCrossRef
21.
23.
24.
Zurück zum Zitat Spirn MJ, Warren FA, Guyer DR, Klancnik JM, Spaide RF (2003) Optical coherence tomography findings in nicotinic acid maculopathy. Am J Ophthalmol 135(6):913–914PubMedCrossRef Spirn MJ, Warren FA, Guyer DR, Klancnik JM, Spaide RF (2003) Optical coherence tomography findings in nicotinic acid maculopathy. Am J Ophthalmol 135(6):913–914PubMedCrossRef
25.
Zurück zum Zitat Dajani HM, Lauer AK (2006) Optical coherence tomography findings in niacin maculopathy. Can J Ophthalmol 41(2):197–200PubMedCrossRef Dajani HM, Lauer AK (2006) Optical coherence tomography findings in niacin maculopathy. Can J Ophthalmol 41(2):197–200PubMedCrossRef
26.
Zurück zum Zitat Jampol LM (1988) Niacin maculopathy: Ophthalmology 95(12):1704–1705PubMed Jampol LM (1988) Niacin maculopathy: Ophthalmology 95(12):1704–1705PubMed
Metadaten
Titel
Retinal toxicity after intracameral use of a standard dose of cefuroxime during cataract surgery
verfasst von
Céline Faure
Daniel Perreira
Isabelle Audo
Publikationsdatum
01.02.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Documenta Ophthalmologica / Ausgabe 1/2015
Print ISSN: 0012-4486
Elektronische ISSN: 1573-2622
DOI
https://doi.org/10.1007/s10633-014-9465-7

Weitere Artikel der Ausgabe 1/2015

Documenta Ophthalmologica 1/2015 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.